Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) largest shareholders are individual investors who were rewarded as market cap surged US$11m last week [Yahoo! Finance]
Rani Therapeutics Holdings, Inc. - Class A (RANI)
Company Research
Source: Yahoo! Finance
editorial-team@simplywallst.com (Simply Wall St) Sat, February 15, 2025 at 1:18 PM GMT+1 4 min read In This Article RANI Key Insights The considerable ownership by individual investors in Rani Therapeutics Holdings indicates that they collectively have a greater say in management and business strategy 46% of the business is held by the top 25 shareholders Insiders have bought recently To get a sense of who is truly in control of Rani Therapeutics Holdings, Inc. ( NASDAQ:RANI ), it is important to understand the ownership structure of the business. And the group that holds the biggest piece of the pie are individual investors with 52% ownership. Put another way, the group faces the maximum upside potential (or downside risk). Clearly, individual investors benefitted the most after the company's market cap rose by US$11m last week. In the chart below, we zoom in on the different ownership groups of Rani Therapeutics Holdings. Check out our latest analysis for Ra
Show less
Read more
Impact Snapshot
Event Time:
RANI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RANI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RANI alerts
High impacting Rani Therapeutics Holdings, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
RANI
News
- Rani Therapeutics (NASDAQ:RANI) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Rani Therapeutics to Participate in the Evercore Healthcare ConferenceGlobeNewswire
- Rani Therapeutics (NASDAQ:RANI) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Osteoporosis Market Set to Expand Significantly During the Forecast Period (2025-2034) Due to Rising Aging Population and Novel Therapeutics | DelveInsight [Yahoo! Finance]Yahoo! Finance
- Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate UpdateGlobeNewswire
RANI
Earnings
- 8/7/25 - Beat
RANI
Sec Filings
- 12/5/25 - Form DEF
- 12/4/25 - Form EFFECT
- 12/3/25 - Form 424B5
- RANI's page on the SEC website